Quiz 2
Dental Hygiene 3121 with Anderson at University of Minnesota - Twin Cities
About this deck
Created: 2010-06-02
Size: 72 flashcards
Views: 30
About StudyBlue
Naj
Sign up (free) to study this.
RELATIVE contraindications
preferable to avoid administering the drug but may be used judiciously/carefully
ABSOLUTE contraindications
=do not administer drug under ANY circumstances...a LIFE-THREATENING risk!
ex) allergies to sulfites or esters, cocaine use, uncontrolled medical conditions
Conditions needing modifications of the agent
-liver disease (limit amide dose)
-alcoholism (limit amide dose)
-heart disease
-kidney disease (limit amide dose)
-AIDS/HIV
Modifications/Decisions
-esters vs amides
-short vs long acting
-vasoconstrictor or not?
-volume
-concentration (kid vs old vs healthy)
ASA I
-normal healthy
-routine care, stress reduction
ASA II
-mild-moderate systemic disease (HBP)
-routine care, stress reduction, limit length of appt
ASA III
-severe systemic disease, NOT incapacitating
-strict limiting of complex procedures, control stress, modifications needed
-incapacitating disease, constant threat to life
-emergency/palliative care only
ASA V
-moribund client, not expected to live
-emergency life support
ASA VI
-clinically DEAD
-maintained for organ harvesting
CV disease: congestive heart failure
-ASA III or IV
-decreased liver function
-limit AMIDE/dose of anesthetic
CV disease: heart attack
-ASA II or IV
-limit vasoconstrictors (.o4 mg per visit)***
-2 cartridges of 1:100,000 epi or 4 cartridges of 1:200,000 = .04 mg
CV disease: angina pectoris
-ASA III if stable
-reduce stress
-may use vasoconstrictors but LIMIT
-follow .04 dose
CV disease: valve defects, murmur, prosthetic valves, pacemakers
-evaluate for antibiotics
-use stress reduction
-can use vasoconstrictors
CV disease: bleeding disorders
-avoid highly vascular areas for injections
CV disease: hypertension
-limit vasoconstrictor dose
-stress reduction
-monitor vitals
CV disease: stroke (CVA)
-use minimum effective dose of the agents
-monitor vitals
LIVER disease/dysfuction
-limit dose of anesthetic to avoid toxicity
-may need to consider an ester
-increased risk of infection
-liver disease, AIDS, jaundice, alcoholism
Kidney disease
-ASA III or IV
-limit dose of AMIDE (not vasoconstrictor)
-potential for toxicity
Thyroid disease
HYPER: more sensitive to amides & esp. vasoconstrictors. Limit dose & avoid vasoconstrictors if uncontrolled
HYPO: no worries if controlled with med, no modifications necessary
Diabetes
-vasoconstrictor may interfere with the action of insulin & glucose uptake
-hyperglycemia is possible
-limit use of vasoconstrictor
**esp insulin dependants
Drug addiction
-do not use epinephrine within 24 hours!!
-may choose not to do treatment
-cocaine: NO VASOconstrictor/epi, but CAN give AMIDE
Epilepsy/Seizures
-no contraindications
-use stress reduction
-overdose to anesthetics may trigger seizures
Sulfite allergy
-avoid use of vasoconstrictors (sodium bisulfites)
-SULFA is OKAY
Pregnancy
-relative contraindication to elective care
-avoid care in first trimester
-use lidocaine with epi or prolicaine= category B
RARE: malignant hyperthermia
-transmitted GENETICALLY
-rise in Ca levels in muscle
-triggered by specific agents like general or local anesthesia
-signs: tachycardia, fever muscle rigidity, cyanosis
-consult physician, use amides in normal dose
RARE: atypical plasma cholinesterase
-underproduction of the enzyme by the liver
-cant hydrolyze ester
-USE AMIDES
-increased risk of apnea with succinylcholine (intubation in surgery, muscle relaxant)
RARE: methemoglobinemia
-oxygen carrying capacity of blood is reduced
-hereditary, congenital or acquired
-usually seen with intravenous injections
-errors in metab of prilocaine in LG dose
-triggers: ink, shoe polish, benzocaine, sulfonamides, nitrates, crayons
-4 hrs after use: lethargic, resp disease, cyanosis, gray skin
-treatment= methylene blue intravenous
Medication Considerations
-some inactivate the drug, others potentiate their action
-vasoconstrictors more often in the tissue
-use reference & physician consult
MEDS: antidepressants/antipsychotics
-tricyclic antidepressants=a RELATIVE contraindication
-LIMIT EPINEPHRINE, avoid others
-accentuate the vasoconstrictor
-elevated systolic blood pressue
MEDS: monoamine oxidase inhibitors
ex: nardil
-unable to inactivate the vasoconstrictor
-RELATIVE contraindication
-minimize the dose of EPI
MEDS: phenothiazines
ex: thorazine
-antipsychotic, also for nausea
-inhibits the vasoconstrictor
-could become hypotensive
-limit EPI
MEDS: beta-blockers (antihypertensive, antiarrythmias) SELECTIVE type
ex: Lopressor
-impairs metabolism of lidocaine
-decreases hepatic flow
-unlikely to cause toxicity in single dose
-affects how much AMIDE to use because LIVER dysfunction...MINIMIZE AMIDE
MEDS: beta-blockers NONSELECTIVE type
ex: inderal
-HYPERTENSIVE response to EPI
-limit dose of EPI, MINIMIZE EPI
-monitor blood pressue
MEDS: antidiabetics
ex: insulin, orinase
-epinephrine conteracts meds, glucose uptake
-LIMIT use of EPINEPHRINE
MEDS: cholinesterase inhibitors
-avoid ESTERS..more slowly metabolized
-topicals should be OK
-for myasthenia gravis, glaucoma
MEDS: sulfonamides
ex: bactrim, septra
-do not use ESTERS
-inhibits bacterial action..makes antibiotic less effective
MEDS: cimetidine
ex: tagamet
-used for GI problems
-potential for toxic response to AMIDES
-limit the AMIDE
Extra Recommendations
-most are only RELATIVE contras
-use the MINIMUM effective dose of the amide and vasoconstrictor
-seek consults and references
-NOT very many ABSOLUTE contras (ester allergy, cocaine use etc)
Toxicity/Overdose: definition
= clinical signs and symptoms resulting from over administration of local anesthesia
SYSTEMIC toxicity:
-most likely from intravascular injection
-incidnce is low & preventable
-blood levels of anesthetic are elevated
-CNS & CVS excitation to depression
Toxicity: client factors altering a normal rxn
-age (young & old)
-weight
-meds
-disease, hepatic and renal function
-genetics, enzyme production
-attitude, environment
Toxicity: drug factors
-vasodilators
-great conc of dose = more mg
-route of administration
-rapid deposition = increase toxicity
-vascularity of area
-use of vasoconstrictors (epi makes it safer)
MRD
-determind by age, weight & physical status
-2-3 mg/lb recommended
-consider MRD & vasoconstrictor
-use the LEAST of the 2 (can have 4 anesthesia but only 2 epi = only use 2!)
CNS Response
-very sensitive to anesthetics
-blood levels > 4.5 ug/ml for overdose
-agitation to respiratory distress
Cardiovascular Response
-less sensitive to anesthetics
-5-10 ug/ml for miner alterations
-over 10 ug/ml for serious complications
-increased heart rate to cardiac arrest
Toxicity: MILD symptoms
-conscious, talkative, agitated, increased vital signs
-slow onset is 5 mins or more
-slower onset is more than 15 mins, lasts longer, increases in intensity could indicate abnormal biotransformation, renal dysfunction
Toxicity: MILD management
-reassure client, get assistance
-give oxygen
-monitor vital signs
-anticonvulsant IV may be needed
-allow to recover, evaluate for transport
-toxicity>seizure>anticonvulsant
Toxicity: SEVERE symptoms
-rapid onset: within ONE minute, unconscious, may have convulsions
-slow onset: large dose, rapid absorption may have renal or hepatic dysfunction
Toxicity: SEVERE management
-elevate feet, slightly supine
-protect from harm
-get emergency help
-use basic life support
-anticonvulsant if longer than 5 mins
-water for post seizure depression
-allow to recover, escort home
Vasoconstrictor Reactions
-too much vasoconstrictor
-intravascular injection
-idiosyncratic response: unusual individually particular response to the patient
Vaso Rxns: clinical manifestations
-fear, anxiety, tense, restless, tremors, perspirationm, weak, dizzy, palor
-heart palpitations
-respiratory difficulty
-high BP and heart rate
-dysrythmias
-hyperventilation
Vaso Rxns: management
-stop procedure
-position semi-erect to supine
-reassure client
-monitor vitals
-oxygen UNLESS hyperventilating
Systemic: allergic rxns
=hypersensitivity acquired through exposure to an allergan
-re-exposure heightens response
-uncommon with AMIDES
-likely due to preservative/antioxidant (sodium bisulfite in epi solutions)
-more common with ESTERS, watch topicals
Systemic: allergic rxn characteristics
-localized or generalized rxn
-mild to major
-immediate or delayed
-most common resp=DERMATOLOGICAL
-bronchospasms
-anaphylaxis
Systemic: allergic rxn dermatological response
=MOST COMMON
-usually not life-threatening
-hives, itching, swelling
-face, hands, feet, lips, tongue, pharynx, larynx, genitalia
DELAYED dermatological management
-delayed, localized
-60 mins or more
-administer oral antihistamine
-50 mg diphenhydramine (2 tablets at 25 mg each)
-medical consultation
IMMEDIATE dermatological management
-less than 60 mins
-.3 ml of 1:1000 epi (epipen) or 1:2000 for kids
-antihistamine IM (50 mg)
-med consult before discharge
-observe for one HOUR
-escort home if epi pen/parenteral drugs were used
-oral antihistamine follow up
Systemic: allergic respiratory response
-bronchospasms
-lower airway distress, wheezing, cyanosis
-laryngeal edema, swelling, obstructs airway
CALL 911!!!!
Systemic: respiratory management
-semi erect position, supine for laryngeal edema
-give oxygen
-use epi or bronchodilator
-observe/monitor for one HOUR
-use epi 1:1000 IM if reoccurs
-oral antihistamine after recovery
-discharge or hospitalize
Systemic: anaphylaxis
-hypersensitive body response
-happens QUICKLY!!
-progresses in 5-30 mins
-can be life threatening
Systemic: anaphylaxis signs
-smooth muscle contractions, bronchospasms, GI, genitourinary
-respiratory distress
-CV collapse, pallor, palpitations
-hypotension, unconcious, cardiac arrest
-death due to laryngeal edema
Systemic: anaphylaxis management
-activate the EMS
-place in supine position
-give EPI
-monitor until help arrives
-follow up with physician
-oral anti-histamines
Systemic: fainting
=most COMMON SYSTEMIC reaction
-contributors: emotional distress, hunger, exhaustion, heat, position, hypervent, coughing, severe cardiac conditions, drugs
-management: supine, feet up, oxygen, inhalant
Local: paresthesia
=persistent anesthesia..resolves within 8 weeks & is rarely permanent
cause: trauma to nerve sheath, hemorrhage around nerve
problem: self injury due to loss of feeling, loss of taste with Li nerve involved
manage: tell pt its temporary, record incident & re examine every 2 months, consult after 1 YEAR
Local: trismus
=motor disturbance of trigeminal nerve, spasm of mastication muscles, opening is hard
-minor but can be chronic
-cause: injection to muscles or blood vessels, hand in hand with hematoma, hemorrhage irritates, low grade infection
-prevent: good technique,limit penetrations & redirecting
Local: trismus management
-apply heat every 20 mins
-muscle relaxants
-anti inflammatory drugs
-movement therapy
Local: hematoma
=the effusion of blood into extravascular spaces
-bruising noted intra and extraorally
-increases in sizze until extravascular pressure equals intravasc or until clots
cause: nicking blood vessel, most common with high vascularity: PSA, IA and mental
Local: hematoma management
-immediately apply pressure at the site of bleeding for 2 mins
-apply cold packs
-DO NOT APPLY HEAT ON SAME DAY!!
Local: facial nerve paralysis
=anesthesia of 7th cranial nerve
-impairment of muscles of mastication
-TEMPORARY symptoms
cause: needle was directed too far posteriorly into PAROTID gland (poor IA or akinosi)
Local: facial nerve paralysis problems
-temporarily loss of motor function
-unilateral
-unable to close the eye
-mostly a cosmetic problem
-lasts a few hours
Local: facial paralysis management
-tell client its transient
-remove contact lenses
-manually close the eye
-review your technique!!
About this deck
Created: 2010-06-02
Size: 72 flashcards
Views: 30
About StudyBlue
Naj